Your search returned 4 results.

Sort
Results
1.
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors:
  • Brewer, H Bryan
PMID:
  • 26047975
Year: 2015
Citation:
  • Lancet. 386(9992):452-60, 2015 Aug 1.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ
2.
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study. [] MedStar authors:
  • Swain, Sandra M
PMID:
  • 25542269
Year: 2015
Citation:
  • Breast Cancer Research & Treatment. 149(1):163-9, 2015 Jan.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bhatt K, Bury MJ, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Goel R, Jacobs SA, Johannes H, Julian TB, Mamounas EP, Provencher L, Rastogi P, Robidoux A, Stella PJ, Swain SM, Tan AR, Thirlwell MP, Wolmark N
3.
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. MedStar authors:
  • Cruz, Allan-Louie
PMID:
  • 28453705
Year: 2017
Citation:
  • Annals of Oncology. 28(5):1050-1056, 2017 May 01
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology/Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barr PM, Brander DM, Cheson BD, Claxton DF, Cruz AL, Daniel C, Fanning M, Foon K, Gashonia L, Goy A, Henick Bachow S, Hill BT, Howlett C, Isaac K, Kennard KH, Kiselev P, Lamanna N, Lenhart J, Mato AR, Nabhan C, Pu JJ, Schuster SJ, Skarbnik AP, Svoboda J, Timlin C, Ujjani CS, Winter AM, Yacur M, Zent CS
4.
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. MedStar authors:
  • Fishbein, Dawn
PMID:
  • 34255381
Year: 2021
Citation:
  • Hepatology. 74(6):2952-2964, 2021 12.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Darling JM, Di Bisceglie A, Dong M, Evon DM, Fishbein DA, Fried MW, Hinestrosa F, Horne PM, Khalili M, Kixmiller S, Lok AS, Michael L, Moon JS, Morelli G, Muir AJ, Nelson DR, Pearlman B, Peter J, PRIORITIZE Study Team, Rajender Reddy K, Segal JB, Sherman KE, Shiffman ML, Sloan A, Stewart PW, Sulkowski MS, Vainorius M, Wadsworth S
Pages

Powered by Koha